Related Experiment Video
Updated: Aug 8, 2026

Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
Differential regulation of retinoblastoma protein function by specific Cdk phosphorylation sites
1Department of Biology, University of California at San Diego, La Jolla, California 92093-0347, USA.
Abstract:
The retinoblastoma tumor suppressor protein, RB, contains at least three distinct protein binding domains. The A/B pocket binds proteins with the LXCXE motif, the C pocket binds the nuclear c-Abl tyrosine kinase, and the large A/B pocket binds the transcription factor E2F. Dissociation of RB from its targets is observed as RB becomes phosphorylated during G1/S progression. There are 16 Cdk consensus phosphorylation sites in RB. It was previously unknown whether the many phosphorylation sites had redundant or distinct functions in the regulation of RB. Using RB mutant proteins lacking specific phosphorylation sites, we show that each of the binding domains is inhibited by different sites. Thr-821/826 phosphorylation is required to inhibit the binding to LXCXE containing proteins. Mutation of these two sites does not interfere with the hyperphosphorylation of RB. However, this phosphorylated mutant retains the ability to bind T-Ag, E7, and Elf-1, all of which contain the LXCXE motif. In contrast, Ser-807/811 phosphorylation is required to disrupt c-Abl binding. Mutation of Ser-807/811 and Thr-821/826 does not abolish the regulation of E2F binding. Taken together, these results show that the protein binding domains of RB are each regulated by distinct Cdk phosphorylation sites.
Insights
Retinoblastoma protein (RB) phosphorylation sites regulate distinct protein binding domains. Specific sites inhibit LXCXE motif binding, while others disrupt c-Abl kinase interaction, revealing domain-specific regulation.
Area of Science:
- Molecular Biology
- Cell Cycle Regulation
- Cancer Biology
Background:
- The retinoblastoma tumor suppressor protein (RB) is crucial for cell cycle control.
- RB possesses multiple protein binding domains, including pockets for LXCXE motif proteins, c-Abl tyrosine kinase, and E2F transcription factors.
- RB's interaction with targets is modulated by phosphorylation during cell cycle progression.
Purpose of the Study:
- To investigate whether the numerous cyclin-dependent kinase (Cdk) phosphorylation sites on RB have redundant or distinct regulatory functions.
- To determine which specific phosphorylation sites regulate the individual protein binding domains of RB.
Main Methods:
- Utilized mutant RB proteins engineered to lack specific phosphorylation sites.
- Assessed the impact of these mutations on the binding affinities of RB to its known protein partners.
Main Results:
- Phosphorylation at Thr-821/826 is essential for inhibiting the binding of LXCXE motif-containing proteins, without affecting overall hyperphosphorylation.
- Mutants lacking Thr-821/826 phosphorylation retain binding to T-Ag, E7, and Elf-1.
- Phosphorylation at Ser-807/811 is required to disrupt binding to the nuclear c-Abl tyrosine kinase.
- Mutations at Ser-807/811 and Thr-821/826 did not abolish the regulation of E2F binding.
Conclusions:
- The distinct protein binding domains of the retinoblastoma tumor suppressor protein (RB) are independently regulated by specific Cdk phosphorylation sites.
- This phosphorylation-dependent regulation provides a mechanism for fine-tuning RB's interactions with various partners during the cell cycle.
More Related Videos
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
12:26Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
Related Concept Videos
Positive Regulator Molecules
Negative Regulator Molecules
Positive Regulator Molecules
Inhibition of Cdk Activity
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Inhibition of CDK Activity